Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300076512Phase 4Recruiting
Phase 4, open-label trial of dezocine, pentazocine, midazolam, propofol and dyclonine in Cirrhosis (4 arms), sponsored by Tianjin Third Central Hospital. Primary endpoints: Respiratory depression during surgery, Hypotension and 19 more. Started May 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300076512.